New hope for hard-to-treat blood cancers?
NCT ID NCT06656494
First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 17 times
Summary
This early-stage trial tests a new drug (ICP-248) combined with a standard chemotherapy (azacitidine) in people with acute myeloid leukemia or myelodysplastic syndromes. The goal is to find a safe dose and see if the combo helps control the disease. About 266 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOGENOUS LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospita
RECRUITINGHefei, Anhui, 230001, China
Contact Email: •••••@•••••
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, 510030, China
Contact Email: •••••@•••••
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nanfang Hospital Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
Contact Email: •••••@•••••
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Royal Perth Hospital
RECRUITINGPerth, Western Australia, 6000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shengjing Hospital of China Medical University
RECRUITINGShengyang, Liaoning, 110004, China
Contact Email: •••••@•••••
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
Contact Email: •••••@•••••
-
St Vincent's Hospital
RECRUITINGSydney, New South Wales, 2010, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, 400042, China
Contact Email: •••••@•••••
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, 215006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310012, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130000, China
Contact Email: •••••@•••••
-
Tianjin People's Hospital
RECRUITINGTianjin, Tianjin Municipality, 300192, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430000, China
Contact Email: •••••@•••••
-
Yale University, Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06520, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.